Inicio › Leucemia linfoblástica aguda › California

Ensayos clínicos de Leucemia linfoblástica aguda en California

40 estudios sobre Leucemia linfoblástica aguda buscan participantes en California.

Ciudades en California

Texto oficial del estudio (inglés)

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

Children's Hospital of Los Angeles, Los Angeles

Reclutando

Edades de 1 a 25 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05621291

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
y 20 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

City of Hope, Duarte
UC Davis, Sacramento
Stanford Health Care, Stanford

ReclutandoFase 1

Edades de 12 a 78 · Todos los sexos · Actualizado el 29 sept 2026 · NCT03802695

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

City of Hope, Duarte
Children's Hospital Los Angeles, Los Angeles

ReclutandoFase 2

6 Months · Todos los sexos · Actualizado el 28 sept 2026 · NCT06514794

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

Stanford University, Palo Alto

ReclutandoFase 1

Edades de 1 a 25 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06408194

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Kaiser Permanente Downey Medical Center, Downey
Loma Linda University Medical Center, Loma Linda
Miller Children's and Women's Hospital Long Beach, Long Beach
y 8 más

ReclutandoFase 1/2

Hasta los 22 · Todos los sexos · Actualizado el 25 ago 2026 · NCT04726241

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

Lucille Packard Children's Hospital of Stanford University, Palo Alto

ReclutandoFase 1

18 Months – 39 Years · Todos los sexos · Actualizado el 21 ago 2026 · NCT07573111

A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

City of Hope Cancer Center (Data collection AND Specimen Analysis), Duarte
Stanford University (Data Collection AND Specimen Analysis), Stanford

ReclutandoFase 2

Edades de 40 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT07400029

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Children's Hospital Los Angeles, Los Angeles
Children's Hospital Orange County, Orange
UCSF School of Medicine, San Francisco

ReclutandoFase 2

Edades de 7 a 25 · Todos los sexos · Actualizado el 19 ago 2026 · NCT05082519

A Study of CTD402 in T-ALL/LBL Patients

Stanford University, Palo Alto

ReclutandoFase 1/2

Edades de 1 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07070219

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Memorial Health Service, Fountain Valley
University of California Los Angeles, Los Angeles

ReclutandoEstudio observacional

1 Day – 17 Years · Todos los sexos · Actualizado el 14 ago 2026 · NCT06274788

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Cedars-Sinai Medical Center, Los Angeles

ReclutandoFase 1

Edades de 18 a 85 · Todos los sexos · Actualizado el 10 ago 2026 · NCT05887167

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

City of Hope Medical Center, Duarte

ReclutandoFase 1

Edades de 18 a 70 · Todos los sexos · Actualizado el 31 jul 2026 · NCT06287944

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

City of Hope Medical Center, Duarte

ReclutandoFase 1Se aceptan voluntarios sanos

Edades de 18 a 75 · Todos los sexos · Actualizado el 28 jul 2026 · NCT07020533

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Rady Children's Hospital, San Diego

ReclutandoFase 4

Edades de 1 a 18 · Todos los sexos · Actualizado el 14 jul 2026 · NCT06289673

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

Research Site, Duarte

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 13 jul 2026 · NCT07109219

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

City of Hope, Duarte
Children's Hospital of Los Angeles, Glendale
Scripps Green Hospital, La Jolla
y 8 más

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

City of Hope Medical Center, Duarte

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 29 jun 2026 · NCT06815003

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Stanford University, Palo Alto

ReclutandoFase 1

Edades de 18 a 70 · Todos los sexos · Actualizado el 23 jun 2026 · NCT06551584

A Study of Revumenib and Mezigdomide in People With Leukemia

City of Hope Cancer Center (Data collection only), Duarte

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 22 jun 2026 · NCT07356154

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

Children's Hospital Los Angeles, Los Angeles
Valley Children's Hospital, Madera
Children's Hospital of Orange County, Orange
y 2 más

ReclutandoFase 1/2

Hasta los 1 · Todos los sexos · Actualizado el 3 jun 2026 · NCT05848687

Pharmacogenomics of Asparaginase Induced Hepatotoxicity

Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 jun 2026 · NCT03568266

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

City of Hope Comprehensive Cancer Center, Duarte
Kaiser Permanente-Oakland, Oakland
Lucile Packard Children's Hospital Stanford University, Palo Alto
y 1 más

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 18 may 2026 · NCT01790152

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

Ascentage Investigative Site #1062, Duarte
Ascentage Investigative Site #1134, Los Angeles
Ascentage Investigative Site #1059, Los Angeles

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 abr 2026 · NCT06051409

Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

City of Hope Medical Center, Duarte

ReclutandoFase 1Se aceptan voluntarios sanos

Edades de 60 en adelante · Todos los sexos · Actualizado el 29 abr 2026 · NCT06195891

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

City of Hope Medical Center, Duarte

ReclutandoFase 1 temprana

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 abr 2026 · NCT06735690

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Hoag Family Cancer Center, Newport Beach
Stanford University, Palo Alto

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 24 mar 2026 · NCT04988555

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

City of Hope, Duarte
Stanford, Palo Alto

ReclutandoFase 2

Edades de 18 a 66 · Todos los sexos · Actualizado el 17 mar 2026 · NCT06859424

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

City of Hope Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine
UC San Diego Moores Cancer Center, La Jolla
y 1 más

ReclutandoFase 2

Edades de 18 a 54 · Todos los sexos · Actualizado el 17 mar 2026 · NCT06918431

Venetoclax Basket Trial for High Risk Hematologic Malignancies

University of California San Francisco-Benioff Children's Hospital, San Francisco

ReclutandoFase 1

Edades de 1 a 40 · Todos los sexos · Actualizado el 12 mar 2026 · NCT05292664

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

City of Hope Medical Center, Duarte

ReclutandoFase 2Se aceptan voluntarios sanos

Edades de 18 a 75 · Todos los sexos · Actualizado el 10 mar 2026 · NCT06059391

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

City of Hope Medical Center, Duarte

ReclutandoFase 1

Edades de 2 en adelante · Todos los sexos · Actualizado el 5 mar 2026 · NCT06575296

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

City of Hope Medical Center, Duarte

ReclutandoFase 2

Edades de 10 a 30 · Todos los sexos · Actualizado el 4 dic 2025 · NCT05194397

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

City of Hope, Duarte

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2025 · NCT04260022

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

City of Hope Medical Center, Duarte

ReclutandoFase 2

Edades de 2 a 22 · Todos los sexos · Actualizado el 31 oct 2025 · NCT06128070

Umbilical Vessel Catheterization Under ECG Monitoring and Guidance

Lucille Packard Children's Hospital, Palo Alto

Reclutando

1 Day – 45 Days · Todos los sexos · Actualizado el 1 may 2025 · NCT03898596

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

City of Hope, Duarte

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 abr 2025 · NCT06462365

Bright Ideas - CIN Feasibility Study

Children's Hospital Los Angeles, Los Angeles

Reclutando

Edades de 4 a 18 · Todos los sexos · Actualizado el 31 ene 2025 · NCT04929899

Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy

Jackie and Gene Autry Orthopedic Center, CHLA, Los Angeles

Reclutando

Edades de 5 a 18 · Todos los sexos · Actualizado el 20 ene 2025 · NCT06096272

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital Los Angeles, Los Angeles
Children's Hospital Orange County, Orange
UCSF School of Medicine, San Francisco

ReclutandoFase 1

Edades de 1 a 21 · Todos los sexos · Actualizado el 6 dic 2024 · NCT05476770

De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.